Encorafenib (LGX818)(1269440-17-6)
- Name: Encorafenib (LGX818)
- Synonyms:LGX 818;LGX818;LGX-818;(S)-Methyl [1-[[4-[3-[5-chloro-2-fluoro-3-(methylsulfonamido)phenyl]-1-isopropyl-1H-pyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate
- Molecular Formula:C22H27ClFN7O4S
- Molecular Weight:540.018
- CAS Registry Number:1269440-17-6
- EINECS:
- Melting Point:
- Water Solubility:
China (Mainland)] 
Assessed
Assessed
Assessed
Assessed
Premium
Premium
United States] 
Premium
Other Product
- 128387-35-9/(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol
- 98361-56-9/(1S,2S)-2-((R)-1-phenylethylaMino)cyclohexanol
- 374795-42-3/1-Oxa-9-azaspiro[5.5]undecane-9-carboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester
- 1108147-88-1/MCOPPB (triHydrochloride)
- 1087740-50-8/2,6-Diazaspiro[3.3]heptane, (Hydrochloride), hydrate (1:2:2)
- 1276666-12-6/4-((2-aminoethyl)(5-chlorobenzo[d]oxazol-2-yl)amino)butan-2-one (dimethanesulfonate)
- 915385-81-8/ABC294640
- 1415560-69-8/PF 02341066 hydrochloride
- 1173900-38-3/(S)-methyl 2-(1-(7-methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoate
- 1380575-43-8/LDK-378 dihydrochloride
- 23491-55-6/Hoechst 33258 analog 5
- 23554-98-5/Hoechst 33258 analog 3
- 1131042-11-9/GSK1720070
- 897732-93-3/JNJ-38431055
- 255374-90-4/WX-UK1
- 701909-57-1/XEN-2174
- 1095173-27-5/PF 04449913
- 1207358-59-5/mTOR inhibitor
- 957209-68-6/NVP-QAV-572
- 1269440-17-6/Encorafenib (LGX818)
- 1251533-99-9/N-(4-chlorophenyl)-1-(pyrimidin-2-yl)-1H-pyrrole-2-sulfonamide
- 1305115-80-3/PF-04957325
- 1085703-32-7/VITAMIN CK3
- 1133432-49-1/GDC0834
- 882759-86-6/Alanine, N,N'-[[5-[2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]pho sphinylidene]bis[2-methyl-, diethyl ester, monomethanesulfonate
- 191801-19-1/BAL-9602
- 945771-74-4/BNC105
- 942149-56-6/DM-CHOC-PEN
- 603288-22-8/LY2090314
- 744208-75-1/NA-808